C3 Anti-TNF Antibodies and Methotrexate in the Treatment of Autoimmune Disease
- Date:
- 1996-2009
- Reference:
- SA/KET/A/4/3/4
- Part of:
- The Kennedy Trust for Rheumatology Research
- Archives and manuscripts
Collection contents
About this work
Description
Series relates to patent C3 "Anti-TNF Antibodies and Methotrexate in the Treatment of Autoimmune Disease," invented by Marc Feldmann and Ravinder Maini under applicant The Kennedy Institute of Rheumatology.
Contains papers relating to the filing and prosecution progress for the U.S. and international PCT, Australian, Canadian, European (EPO) applications. Also contains continuation and divisional application papers as well as opposition papers.
See related material for multiple C3 Espacenet listing (includes patent abstract and digital copies of application).
Publication/Creation
1996-2009
Physical description
4 boxes